Skip to Main Content

INFORMATION FOR

Sarah Elizabeth Schellhorn, MD

Associate Professor of Medicine (Medical Oncology); Chief, Ambulatory Officer

Contact Information

Sarah Elizabeth Schellhorn, MD

Patient Care Locations

Mailing Address

  • Medical Oncology

    25 York Street, PO Box 208028

    New Haven, CT 06510

    United States

Appointments

Biography

I am an Associate Professor of Medicine in the section of Medical Oncology within the Department of Medicine, and in the clinic, I see patients with breast cancer. I am also involved in education of students, residents, and fellows here at Yale. Outside of the clinic, I am involved with the COPPER (Cancer Outcomes, Public Policy, and Effectiveness Research) Center within the School of Medicine, with a specific interest in chemotherapy regimens used in the treatment of breast cancer and how they are used in clinical practice.

Learn more about Dr. Schellhorn>>

Education & Training

  • Fellowship
    M.D. Anderson Cancer Center (2013)
  • Residency
    Beth Israel Deaconess Medical Center (2009)
  • MD
    Weill Cornell Medical College (2006)
  • BA
    Harvard College (2000)

Activities

  • ASCO Breast Cancer Case Discussion
    New Haven, CT, United States 2019
    Yale Cancer Center ASCO Review
  • Outcomes of Real-World Use of Eribulin Plus Trastuzumab for HER2-Positive Metastatic Breast Cancer
    San Antonio, TX, United States 2018
    San Antonio Breast Cancer Symposium
  • Prioritization of patient reported outcomes (PROs) by women with metastatic breast cancer (MBC).
    San Antonio, TX, United States 2018
    San Antonio Breast Cancer Symposium
  • Using Text Messaging and Mobile Health to Guide and Improve Oncology Care
    New Haven, CT, United States 2018
    Yale Therapeutic Radiology Grand Rounds
  • Using Text Messaging and Mobile Health to Guide and Improve Oncology Care
    Greenwich, CT, United States 2018
    Greenwich Hospital Grand Rounds
  • Updates in Breast Cancer
    New Haven, CT, United States 2018
    Yale Cancer Center ASCO Review
  • A 3-D View of Novel Targeted Agents in Metastatic, Hormone-Receptor Positive, HER2 Negative Breast Cancer
    Conway, NH, United States 2018
    Invited Lecture
  • Using Text Messaging and Mobile Health to Guide and Improve Cancer Care
    San Francisco, CA, United States 2018
    Using Text Messaging and Mobile Health to Guide and Improve Cancer Care
  • The Use of Text Messaging to Guide and Improve Patient Care
    San Diego, CA, United States 2017
    Annual American Society of Therapeutic Radiology and Oncology Meeting
  • Advances in Breast Cancer Treatment: anti-HER2 Therapy, PARP inhibitors, and Immunotherapy: ASCO Highlights
    Oklahoma City, OK, United States 2017
    ASCO
  • Updates in Breast Cancer
    New Haven, CT, United States 2017
    Yale Cancer Center ASCO Review
  • Development of an interactive text messaging tool to improve adherence with adjuvant endocrine therapy: Breast cancer endocrine therapy adherence (BETA) pilot study
    San Antonio, TX, United States 2015
    San Antonio Breast Cancer Symposium
  • Updates in Breast Cancer
    New Haven, CT, United States 2014
    Yale Cancer Center ASCO Review
  • San Antonio Breast Cancer Symposium 2013: Review of Adjuvant Trials
    New Hyde Park, NY, United States 2014
    Post-San Antonio Breast Cancer Symposium
  • 10-year Outcomes of Breast Cancer Patients with Histologically-Confirmed Axillary Lymph Node Metastases and pCR after Primary Systemic Chemotherapy
    Alexandria, VA, United States 2013
    Annual Meeting of the American Society of Clinical Oncology
  • Hormonal Therapy in Breast Cancer Treatment and Prevention
    Houston, TX, United States 2013
    Physician Assistant Clinical Pharmacology Curriculum
  • Improving Time to Cancer Diagnosis in an Underserved Population
    Alexandria, VA, United States 2013
    American Society of Clinical Oncology
  • Patterns of the Use of Primary Systemic Chemotherapy in the United States.
    San Antonio, TX, United States 2013
    San Antonio Breast Cancer Symposium

Honors & Recognition

AwardAwarding OrganizationDate
David S. Fischer MD Annual Teaching Award, given for outstanding teaching and mentoring fellows in medical oncologyYale Cancer Center2019
David S. Fischer MD Annual Teaching AwardYale Cancer Center2016
Quality Care Symposium Merit Award, Feasibility and savings of a suspicion of cancer clinic at a large county hospital.Conquer Cancer Foundation of the American Society of Clinical Oncology2012
Clifton Howe Award, given for clinical excellence to medical oncology fellowMD Anderson Cancer Center2011
Henry Adelman Memorial Award for Excellence in Geriatric MedicineWeill Medical College of Cornell University2006
Honor Medical SocietyAlpha Omega Alpha2005
Medical Student ScholarHartford Foundation/Samuels Foundation/American Federation on Aging Research2003
Student FellowEndocrine Society1999
Honorary Harvard College ScholarshipHarvard University1996, 1997, 1998, 1999, 2000

Professional Service

OrganizationRoleDate
BMC Cancer (BioMed Central) (ad hoc)Reviewer2019
Cancer Investigation (ad hoc)Reviewer2019
Protocol Review CommitteeMember2019
Journal of Clinical Oncology (JCO) Clinical Cancer InformaticsEditor2019
Ambulatory Care Committee (Steering Committee)Member2019
Southwest Oncology Group (SWOG) Symptom Control and Quality of Life CommitteeMember2018
Southwest Oncology Group (SWOG) Digital Engagement Committee (Breast Committee Liaison, Survey Working Group)Member2018
Southwest Oncology Group (SWOG) Breast Cancer CommitteeMember2018
Infinite StrengthInfinite Strength is a non-profit organization whose mission is to make medical treatments accessible for underserved patients with breast cancer and to offset comfort care costs that can make all the difference in the healing process, both physically and emotionally.2018 - Present
Breast Cancer Research and Treatment (ad hoc)Reviewer2017
Journal of National Comprehensive Cancer Network (ad hoc)Reviewer2017
Scalp Cooling CommitteeMember2017
Journal of Oncology (ad hoc)Reviewer2016
NP1 Ambulatory Floor ChiefLead2016
Environment & Human Health, Inc.Environment and Human Health, Inc. (EHHI) is a ten-member, science-based organization composed of physicians, public health professionals and policy experts dedicated to protecting human health from environmental harms through research, education and the promotion of sound public policy.2016 - Present
Clinical Therapeutics (ad hoc)Reviewer2015
Smilow Cancer Hospital/Yale Cancer Center Oral Chemotherapy Task ForceMember2014
Smilow Cancer Hospital/Yale Cancer Center Clinical Pathways CommitteeMember2014
SWOG Cancer Care Delivery Research CommitteeMember2013 - 2018
Southwest Oncology Group (SWOG)Member2013
Certificate in Medical Quality (CMQ)Participant2013
Smilow Cancer Hospital/Yale Cancer Center Ambulatory Clinic CommitteeMember2013
American Society of Clinical Oncology (ASCO)Member2010

Departments & Organizations